Wockhardt Limited — Financials & Forensics
Sector: Healthcare · NSE: WOCKPHARMA · BSE: 532300 · ISIN: INE049B01025
09 Sep 2026
Add WOCKPHARMA to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹3,230 Cr | ₹2,651 Cr | ₹2,798 Cr | ₹3,012 Cr | ₹3,373 Cr |
| EBITDA | ₹298 Cr | ₹101 Cr | ₹39 Cr | ₹393 Cr | ₹652 Cr |
| EBITDA margin | 9.2% | 3.8% | 1.4% | 13.1% | 19.3% |
| Profit after tax | ₹-279 Cr | ₹-621 Cr | ₹-472 Cr | ₹-57 Cr | ₹199 Cr |
Deeper analysis
Recent filings by Wockhardt Limited
-
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR) Regulations, 201
10 Aug 2026 · General Update
-
Pursuant to Regulation 32(6) of SEBI (LODR) Regulations 2015, read with Regulation 173A of SEBI (ICD
10 Aug 2026 · Regulatory Compliance
-
Please find enclosed Press Release - "Wockhardt Antibiotic Academy, an initiative for Patient-Centri
10 Aug 2026 · General Update
-
Press Release
10 Aug 2026 · Financial Results
-
Pursuant to Regulation 30 of SEBI Listing Regulations, Board of Directors at its meeting held today
10 Aug 2026 · Board Meeting
Never miss a filing again
About Wockhardt Limited on Indian Stock Alerts
Indian Stock Alerts tracks Wockhardt Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.